Clinical Trial Update: Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial

View source ↗

Summary

Biomarker analyses in tissue samples from patients with Hodgkin lymphoma enrolled in the ECOG-ACRIN ECOG-2496 trial; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Lymphoma | Status: COMPLETED